Key Sessions
Catherine Gray
Key FDA Developments and Practical Compliance Take Aways
US Food and Drug Administration (FDA)
James Stansel
PhRMA (Pharmaceutical Research and Manufacturers of America) Address
PhRMA
Amy Bedsaul
Transparency Reporting: Centers for Medicare & Medicaid Services (CMS) Open Payments Program
Centers for Medicare & Medicaid Services (CMS)
Fabiana Lacerca-Allen
SOFT SKILL LAB Adverse Compliance Event: How to Navigate and Manage a Crisis
Aimmune Therapeutics
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 3 - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day 3 - ET (Eastern Time, GMT-05:00)
search
Streams
Formats
7:30am - 8:30am
Conference Registration and Continental Breakfast
Power Hour - This interactive format is designed to ignite fresh ideas and drive industry collaboration
Showing 3 of 3 Streams
Power Hour A
Power Hour B
Power Hour C
8:30am - 9:30am
Patient Support - The Future of Company-Sponsored Free Genetic and Diagnostic Testing Programs
- Update DOJ and OIG on free testing
- Implications for wider diagnostic testing
- Anti-kickback risks
- Implications of recent OIG opinion on one-time genetic test or treatment approval
- David King - Executive Director, Head of US Compliance, Alexion Pharmaceuticals
- Andrea Kocharyan - Vice President, Legal Development & Compliance, Legal & Intellectual Property, uniQure
9:30am - 10:30am
Social Media, Key Opinion Leaders (KOLs) and Digital Opinion Leaders (DOLs)
- What are your guardrails and parameters on influencers?
- What do you allow commercial folk to say when it comes to promoting your product?
- What does your social media policy look like?
- How do you monitor social media? 3rd party? Monitoring via AI?
- Jill Atstupenas - Director, Compliance, Syndax Pharmaceuticals, Inc.
8:30am - 9:30am
SOFT SKILL LAB Pitch, Present, Persuade: How to Become a Powerful Corporate Communicator
- How to prepare and write compelling presentations: discover the secrets of brilliant presenting
- How to grab and maintain attention: make sure your audience is hearing what you want them to hear
- How to look and sound impressive: learn the tricks that the best presenters use
- Alyssa Zeff - Vice President, Davis & Company - Internal Communication Strategy Experts
9:30am - 10:30am
Managing M&A and Licensing Agreements
- Navigate the roles of Compliance, finance, and investor relations
- Uncover relevant risk areas and overcome key challenges that could arise during joint ventures and M&A
- Assess the impact of CIAs during M&A
- Key considerations including DOJ Guidance
- Integration phase – Experience post-acquisition impact on employee and Compliance framework
- How to prepare for being acquired and to acquire another company
- Gregory Moss - Chief Corporate Strategy, Legal Officer and Chief Compliance Officer, Evommune Inc.
8:30am - 9:30am
Creating a Speak-Up Culture of Compliance
- Dissecting practical approaches of successful campaigns
- How to cultivate a culture of Compliance: from creating open lines of communication to overcoming information barriers
- Practical campaign insight: what components were most beneficial in building awareness?
- How do you become ‘the voice’ of Ethics and Integrity in your organization?
- Masha Goodman-Khan - Senior Director of Compliance & Legal Operations, Vericel Corporation
- Molly Joyce - Vice President, Ethics and Compliance Officer, Global Internal Investigations, AbbVie
- Loren Becher - Senior Director, Ethics & Compliance Programs and Operations, Emergent BioSolutions
9:30am - 10:30am
SOFT SKILL LAB Adverse Compliance Event: How to Navigate and Manage a Crisis
- Essential steps you must take to manage a crisis effectively
- Developing resilience: how to keep a clear head and enable your company to thrive
- Conducting high-profile investigations and preparing for crisis communications
- Fabiana Lacerca-Allen - Senior Vice President, Compliance, Aimmune Therapeutics
- Sheila Folayan - U.S. Compliance Officer, Dompe U.S.
- Randy Bagwell - Senior Director, Europe Division and Senior IHL Policy Advisor, American Red Cross
10:30am - 11:00am
Networking Break
Showing 1 of 1 Streams
Main Stage
11:00am - 11:45am
Where is the Industry in Terms of Diversity, Equity & Inclusion (DE&I)?
- Intersection between Compliance and DE&I programs in pharmaceutical organizations: where and when is it appropriate for Compliance leaders to get involved?
- New trends and developments impacting DE&I: evaluating recent changes in public perception
- Are new policy developments and AI forces for good or is bias and inequality baked into the system?
- Managing the Compliance implications of lack diversity: practical implications, navigating reputational concerns for your business
- Sujata Dayal - Independent Board Director, Emergent BioSolutions
11:45am - 12:15pm
PhRMA (Pharmaceutical Research and Manufacturers of America) Address
- Impact of recent legislative and administrative developments on drug pricing, reimbursement, and access
- US consensus framework: a model for healthcare compliance
- Rebate rule redux and the impact of Loper Bright
- Implications of Pharmacy Benefit Manager (PBM) reform for manufacturers
- 340B Drug Pricing Program developments
- James Stansel - Executive Vice President, General Counsel and Corporate Secretary, PhRMA
12:15pm - 1:45pm
Networking Lunch
Showing 1 of 1 Streams
Main Stage
1:45pm - 2:15pm
Key FDA Developments and Practical Compliance Take Aways
- Gain insight into the current priorities at the FDA’s Office of Prescription Drug Promotion
- Regulator insight into the monitoring activities undertaken by organizations
- Catherine Gray - Director, Office of Prescription Drug Promotion, US Food and Drug Administration (FDA)
2:15pm - 2:45pm
Transparency Reporting: Centers for Medicare & Medicaid Services (CMS) Open Payments Program
- Feedback on audits and lessons learned for the industry to be aware of and apply
- Vision and CMS focus going forward
- Data insight: how do regulators and investigators use the data? How can companies ensure they know what is in the data and what should they expect regulators to know about their data?
- Amy Bedsaul - Open Payments Communications, Centers for Medicare & Medicaid Services (CMS)
- Veronika Peleshchuk Fradlin - Director of Division of Transparency Projects (DTP), Centers for Medicare and Medicaid Services (CMS)
2:45pm - 2:50pm
Close of Conference
Filter
Streams
Formats